Position in IART
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,852,876
-$530,807 QoQ
Shares Held
196,696
+2.5% QoQ
Ownership
0.253%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in IART Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,885 across 83 Medical Devices names. IART ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in IART
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,852,876 | 196,696 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,383,683 | 191,923 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,891,794 | 201,800 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,492,736 | 203,157 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,251,436 | 193,335 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,557,183 | 200,934 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,773,182 | 207,660 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,326,847 | 217,119 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $7,071,955 | 199,491 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,217,793 | 211,660 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,571,745 | 224,450 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,409,639 | 228,778 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,437,097 | 234,055 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,254,779 | 236,397 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,514,733 | 224,616 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $11,675,450 | 216,092 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,830,858 | 199,671 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $13,642,044 | 203,643 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,655,322 | 199,406 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,909,222 | 203,828 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $14,255,892 | 206,338 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $13,543,026 | 208,611 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,764,576 | 206,789 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,980,816 | 212,403 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,365,288 | 209,655 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||